Sphera Funds Management Ltd. Pmv Pharmaceuticals, Inc. Transaction History

Sphera Funds Management Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$9.23 - $22.43 $1.73 Million - $4.21 Million	187,800 New	187,800 $2.68 Million
Q1 2022 May 16, 2022	SELL	$14.86 - $23.55 $2.83 Million - $4.49 Million	-190,525 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$26.84 - $36.58 $2.86 Million - $3.89 Million	106,451 Added 126.62%	190,525 $5.68 Million
Q2 2021 Aug 17, 2021	BUY	$28.01 - $36.01 $1.14 Million - $1.47 Million	40,718 Added 93.92%	84,074 $2.87 Million
Q1 2021 May 17, 2021	BUY	$30.66 - $49.5 $1.33 Million - $2.15 Million	43,356 New	43,356 $1.43 Million

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $72.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.